Core Insights - Daxor Corporation has launched a new Blood Volume Analysis (BVA) program at a healthcare center in the Tampa Bay region of Florida, enhancing fluid management and treatment outcomes for various medical conditions [1][3] - The facility will utilize Daxor's CLIA-certified ezBVA Lab, which provides blood volume analysis results within 24 hours [2] - Daxor's technology offers 98% accurate blood volume measurements, allowing for customized fluid management strategies, which can lead to improved patient outcomes and reduced healthcare costs [3] Company Overview - Daxor Corporation is recognized as the global leader in blood volume measurement technology, having developed the BVA-100, the only FDA-cleared diagnostic blood test for quantifying blood volume status [4] - Over 65,000 tests have been conducted at leading hospitals in the U.S., significantly improving performance metrics in various medical conditions, particularly in reducing mortality and readmissions for heart failure and critical care patients [4] - The company is engaged in ongoing trials for heart failure treatment with support from the NIH and is developing analyzers for combat casualty care in collaboration with the U.S. Department of Defense [4]